Co-managing glaucoma in 2022: The OD/MD angle

Video
Conference|SECO

Mitch Ibach, OD, FAAO and Michael Greenwood, MD review their SECO 2022 presentation on comanaging glaucoma

Doctors Mitch Ibach, optometrist and Michael Greenwood, cataract, cornea, glaucoma and refractive surgeon at Vance Thompson Vision based in Sioux Falls, South Dakota, speak with Optometry Times®' Brooke Henson on comanaging glaucoma in 2022 during the annual SECO meeting.

Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
Related Content
Conference audience Image credit: AdobeStock/John

Top takeaways from the 2024 meeting of the American Academy of Optometry

Emily Kaiser Maharjan, Assistant Managing Editor
December 16th 2024
Article
Expanding the treatment arsenal in glaucoma management

Expanding the treatment arsenal in glaucoma management

Melissa Tawa, OD, FAAO;Deborah Ristvedt, DO;Inder Paul Singh, MD;Arsham Sheybani, MD
August 31st 2024
Podcast
Business people shaking hands Image credit: AdobeStock/NAMPIX

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options

David Hutton, Managing Editor, Ophthalmology Times
December 11th 2024
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Man holding cigarette and whiskey glass at table Image credit: AdobeStock/Parkin

BMI, tobacco, and alcohol: Roles in glaucoma progression examined in study

Lynda Charters
December 3rd 2024
Article
Glasses on pink backdrop Image credit: AdobeStock/АнатолийСав

A dazzling Vision Expo West pairs showmanship with education and research

Emily Kaiser Maharjan, Assistant Managing Editor;Jordana Joy, Associate Editor
November 28th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.